RE:RE:It takes money to advance oncology R&D
this additional indication talk is just a bunch more smoke. They have discussed it for 7+ years and the reality is, no one is going to invest in additional indications until NMIBC is proved. If anyone . Per the Md&a's, Tlt is quoted 3-5 times that btd was to b Received in dec 2022. Also, the Covid research was supposed completed q4 2022. The Covid excuse doesn't work anymore. The fact that management just alters their corporate presentation kick the timeline down the road w explanation is on them. They are still taking their salaries, bonuses, etc and they never perform to meet their own timelines. In regards to warren buffet, he is a great investor, but he would never even consider Tlt due to its record, management, bod, etc. he's smarter than ua